-The Business Standard CVC says provide protection to officer, investigate corruption; MCI president denies all allegations Union Health minister Harsh Vardhan has kicked up yet another controversy by ordering the removal of the chief vigilance officer of the Medical Council of India (MCI), H K Jethi, instead of providing him protection after he complained of harassment and threats. This is the second time Vardhan has decided to remove an anti-graft officer. Earlier, he...

-Outlook India has the potential to lead the world in creating just and equitable societies, the head of UN's women empowerment body has emphasised and said men and boys can play an important role in achieving gender equality. "We need India in the leadership in changing status of women. For me it is very important that India leads in the kinds of changes that you want to see see 20 years after...

-Outlook Kanpur: Indian Medical Association (IMA) will be providing free medical facilities and create awareness about good Health practices in the villages adopted by it under the 'Saansad Adarsh Gram Yojana'. "We have been directed by the IMA headquarters to adopt villages here which will be visited by a team of doctors once in a month. "Free medical facilities will be provided to the villagers and a cleanliness campaign will be launched to...

-Outlook Karnataka government plans to procure cloth from powerlooms for school uniforms, thus impacting the livelihood of handloom weavers in the state. The Vidya Vikas scheme of the government of Karnataka through which free handloom cloth for a pair of uniforms is provided to students of government schools is under a serious threat. Launched about 25 years ago, this unique scheme was designed to serve a dual purpose. The handloom cloth...

-Down to Earth Pharma company's strategy of different prices for different countries to affect quality treatment of 185 million people infected with Hepatitis C worldwide Health activists and agencies on Tuesday criticised leading pharmaceutical company Bristol-Myers Squibb (BMS)'s commercial strategy to sell new Hepatitis C medicine Daclatasvir, stating it would exclude a large number of patients who cannot afford expensive treatment. BMS had announced that it would create a tiered pricing strategy for...